Guizhou Bailing Group Pharmaceutical Co., Ltd. (SHE:002424)

Market Cap	6.25B -14.6%
Revenue (ttm)	2.93B -9.9%
Net Income	-100.35M
EPS	-0.07
Shares Out	1.37B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,542,200
Open	4.440
Previous Close	4.540
Day's Range	4.440 - 4.620
52-Week Range	4.080 - 6.940
Beta	0.29
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 25, 2026

About SHE:002424

Guizhou Bailing Group Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells medicines in China. It operates through four segments: Industrial, Commerce, Medical institutions, and Others. The company offers medicines in various forms, including tablets, tinctures, decoctions, capsules, granules, syrups, powders, pills, dews, pastes, and sprays, as well as wines and honey. Its products are used for cardiovascular, cerebrovascular, cough, cold, gynecological, and pediatric areas. The company was incorp...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 5,715
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002424

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 29, 2026

Data Sources Report a data error